What's new in DyslipidemiaLast update of the site: Wednesday, 12 August 2026

Kothari, Aditia et al. | Current Opinion in Cardiology. Volume...
Atherosclerosis is recognized as a chronic inflammatory disease, with high-sensitivity C-reactive protein...
Gao, Miaolei MS et al. | Pancreas. Volume 55(7).
Current management strategies for Hypertriglyceridemic acute pancreatitis (HTGP) predominantly rely on...
Dong, Bingtian et al. | Cardiovascular Diabetology. Volume 25(1)....
Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with increased cardiovascular...
Chen, Lianzhi et al. | Rheumatology and Therapy. Volume 13(4)....
Interstitial lung disease (ILD) is a progressive fibrotic condition that markedly reduces survival and...
Rallidis, Loukianos S.a et al. | Coronary Artery Disease. Volume 37(6)....
Lipoprotein(a) [Lp(a)] is a causal risk factor for cardiovascular disease, and it is particularly associated...

Bibliographical searchFocus and target to your research of scientific data

Research by journal
1149 articles currently available
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9

Top articlesThe 5 most read articles

Kothari, Aditia et al. | Current Opinion in Cardiology. Volume...
Atherosclerosis is recognized as a chronic inflammatory disease, with high-sensitivity C-reactive protein (hs-CRP) serving as a biomarker of cardiovascular risk that persists despite optimal control of...
Rallidis, Loukianos S.a et al. | Coronary Artery Disease. Volume 37(6)....
Lipoprotein(a) [Lp(a)] is a causal risk factor for cardiovascular disease, and it is particularly associated with premature acute coronary syndrome (ACS). We investigated whether elevated Lp(a) can predict...
Gao, Miaolei MS et al. | Pancreas. Volume 55(7).
Current management strategies for Hypertriglyceridemic acute pancreatitis (HTGP) predominantly rely on lipid-lowering agents and sequential insulin-mediated triglyceride reduction. However, the comparative...
Dong, Bingtian et al. | Cardiovascular Diabetology. Volume 25(1)....
Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with increased cardiovascular disease (CVD) risk. Lipoprotein(a) [Lp(a)] and insulin resistance (IR) are established cardiovascular...
Chen, Lianzhi et al. | Rheumatology and Therapy. Volume 13(4)....
Interstitial lung disease (ILD) is a progressive fibrotic condition that markedly reduces survival and increases mortality in patients with rheumatoid arthritis (RA). Dysregulated lipid metabolism is associated...